Breakthrough In Gene Therapy Could Treat Blindness

Breakthrough In Gene Therapy Could Treat Blindness

Age-related Macular Degeneration (AGM) is one of the leading causes of vision loss. Due to a whole host of faulty genes, AGM was thought to have no viable treatment. That is until now. A report published today in The Lancet suggests that we may be closer to a treatment for Macular Degeneration than we originally thought.

Robert MacLaren from the University of Oxford and his colleagues reported that they have effectively employed gene therapy to treat the rare eye disease, Choroideremia.

Choroidemeria affects one out of every 50,000 people, and though less common than Macular Degeneration, is another degenerative eye disease that causes individuals to go blind. The disease is caused by a defect in the CHM gene that prevents the body from producing a much needed protein called REP-1. Without REP-1 cells in the retina deteriorate and eventually die off leading to blindness.

The trial involved six patients who each contained a different stage of the disease. Each patient received an injection carrying a virus containing the corrective copy of the CHM gene into one of their retinas. The other eye was left alone to be used later for comparison.

Gene Therapy

Gene Therapy (Credit:

Two male patients saw significant improvement to their impaired eyesight, while the four others appeared to have stabilized their vision.

This gene therapy is not to be confused with stem-cell therapy in that it cannot replace cells already dead. The gene therapy can only help to heal already sick cells and prevent healthy ones from deteriorating.

Further studies will need to be conducted to see the effect this sort of gene therapy treatment has on the patients. In the past, while gene therapy worked to cure one ailment, it led to others and even death down the line. Not to mention, it is still too soon to see how long the treatment will last.

James Bainbridge from the Institute of Ophthalmology at University College London explains that “given the relatively slow degeneration in this condition, longer-term studies will be required.”

The implications of this study are remarkable and could lead to break-throughs in the more common and complex cause of blindness—Macular Degeneration.

Share This
Don't be shellfish...Share on Facebook22Tweet about this on Twitter11Share on Google+1Share on StumbleUpon0Digg thisShare on Reddit0Email this to someone

About the author


Jacqueline has a Bachelor of Art degree in english literature from St. John’s University and a Master of Science degree in communication from Pepperdine University. Prior to The Future of Things, Jacqueline wrote for a number of startups and businesses in various industries, ranging from beauty to the financial sector. Over the last year her primary focus has been in affiliate marketing, where she acquired her taste for emerging technologies and technical writing.

View all articles by Jacqueline